Overview

Update
Status
Acquired by on December 1, 2014
IPO / Stock
Went Public on Apr 14, 2000 / NASDAQ:AVNR
Headquarters:
Aliso Viejo, CA
Description:
Avanir Pharmaceuticals is a biopharmaceutical company focused on providing medicines to patients with central nervous system disorders.
Categories:
Medical Device, Biotechnology, Health Diagnostics
Website:
http://www.avanir.com
Social:

Company Details

Update

Avanir Pharmaceuticals is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of their commitment, they have extensively invested in their pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones.

Funding Rounds (2) - $46.2M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2012$30M / Debt Financing2
Oct, 2005$16.2M / Private Equity2

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • Office

    20 Enterprise, Suite 200

    Aliso Viejo, CA 92656

    USA

Past Team (1)

Update

Images (1)

Update

Add Acquisitions

Add Current Team

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos